文献速递主动脉疾病

肾下腹主动脉瘤腔内修复术后一年瘤囊动态与再干预及破裂相关

One-year aneurysm-sac dynamics are associated with reinterventions and rupture following infrarenal endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2023-10-14

基于血管质量倡议与Medicare数据,纳入16,102例首次EVAR且有术后1年影像的患者。与瘤囊稳定相比,瘤囊回缩与8年死亡、再干预和破裂风险降低相关,瘤囊扩张与死亡和再干预风险升高相关。

要点

  • 术后1年瘤囊回缩与8年死亡、再干预及破裂风险降低相关。
  • 术后1年瘤囊扩张与8年死亡和再干预风险升高相关,破裂风险无显著差异。
  • 瘤囊回缩或扩张的程度似乎与远期结局风险呈递增关联。

核心结论

  • EVAR术后1年影像显示瘤囊回缩和扩张分别与远期死亡、再干预和破裂风险降低和升高相关。
  • 瘤囊回缩或扩张的程度似乎也与这些远期结局呈递增关联。

研究设计与样本

  • 回顾性队列研究,纳入2003至2018年血管质量倡议中首次因完整腹主动脉瘤行EVAR并链接Medicare索赔数据的患者。
  • 纳入术后1年有影像学检查的患者,共31,185例EVAR患者中16,102例(52%)被纳入。
  • 瘤囊行为按血管外科学会指南定义:稳定(<5 mm变化)、回缩(≥5 mm)、扩张(≥5 mm)。

主要发现

  • 术后1年,44%瘤囊稳定,49%回缩,6.2%扩张。
  • 与稳定瘤囊相比,回缩组8年死亡率49% vs 53%(HR 0.92,95%CI 0.85-0.99,P = .036),再干预率8.9% vs 15%(HR 0.58,95%CI 0.50-0.68,P < .001),破裂率2.0% vs 4.0%(HR 0.45,95%CI 0.29-0.69,P < .001)。
  • 与稳定瘤囊相比,扩张组8年死亡率64% vs 53%(HR 1.31,95%CI 1.14-1.51,P < .001),再干预率27% vs 15%(HR 1.98,95%CI 1.57-2.51,P < .001),破裂率7.2% vs 4.0%(HR 1.61,95%CI 0.88-2.96,P = .12)。
  • 多项式样条插值显示,与1年无直径变化相比,瘤囊回缩程度越大远期结局风险越低,扩张程度越大远期结局风险越高。

局限性

  • 未来需研究如何改善1年瘤囊回缩,以及延长回缩瘤囊患者随访间隔是否安全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: One-year aneurysm sac changes have previously been found to be associated with mortality and may have the potential to guide personalized follow-up following endovascular aneurysm repair (EVAR). In this study, we examined the association of these early sac changes with long-term reintervention and rupture. METHODS: We identified all patients undergoing first-time EVAR for intact abdominal aortic aneurysm between 2003 and 2018 in the Vascular Quality Initiative with linkage to Medicare claims for long-term outcomes. We included patients with an imaging study at 1 year postoperatively. Aneurysm sac behavior was defined as per the Society for Vascular Surgery guidelines: stable sac (<5 mm change), sac regression (≥5 mm), and sac expansion (≥5 mm). Outcomes included mortality, reintervention, and rupture within 8 years, which were assessed with Kaplan-Meier methods and multivariable Cox regression analysis. Secondarily, we utilized polynomial spline interpolation to demonstrate the continuous relationship of diameter change to 8-year hazard of reintervention, rupture, or mortality as a composite outcome. RESULTS: Of 31,185 EVAR patients, 16,102 (52%) had an imaging study at 1 year and were included in this study. At 1 year, 44% of sacs remained stable, 49% regressed, and 6.2% displayed expansion. Following risk adjustment, compared with a stable sac at 1 year, sac regression was associated with lower 8-year mortality (49% vs 53%; hazard ratio [HR], 0.92; 95% confidence interval [CI], 0.85-0.99; P = .036), reintervention rate (8.9% vs 15%; HR, 0.58; 95% CI, 0.50-0.68; P < .001), and rupture rate (2.0% vs 4.0%; HR, 0.45; 95%CI, 0.29-0.69; P < .001). Conversely, compared with a stable sac, sac expansion was associated with higher 8-year mortality (64% vs 53%; HR, 1.31; 95% CI, 1.14-1.51; P < .001) and reintervention rate (27% vs 15%; HR, 1.98; 95% CI, 1.57-2.51; P < .001), but similar risk of rupture (7.2% vs 4.0%; HR, 1.61; 95% CI, 0.88-2.96; P = .12). Polynomial spline interpolation demonstrated that, compared with no diameter change at 1 year, increased sac regression was associated with an incrementally lower risk of late outcomes, whereas increased sac expansion was associated with an incrementally higher risk of late outcomes. CONCLUSIONS: Following EVAR, compared with a stable sac at 1-year imaging, sac regression and expansion are associated with a lower and higher risk respectively of long-term mortality, reinterventions, and ruptures. Moreover, the amount of regression or expansion seems to be incrementally associated with these late outcomes, too. Future studies are needed to determine how to improve 1-year sac regression, and whether it is safe to extend follow-up intervals for patients with regressing sacs.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rastogi V, O'Donnell TFX, Marcaccio CL, et al. One-year aneurysm-sac dynamics are associated with reinterventions and rupture following infrarenal endovascular aneurysm repair. J Vasc Surg. 2023. PMID: 37844849. doi:10.1016/j.jvs.2023.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。